CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $6,580,000 | -12.8% | 65,715 | -6.4% | 0.07% | -22.0% |
Q4 2016 | $7,547,000 | -17.1% | 70,188 | -4.1% | 0.09% | -12.5% |
Q3 2016 | $9,108,000 | +22.4% | 73,170 | +4.6% | 0.10% | -12.6% |
Q2 2016 | $7,440,000 | +5.5% | 69,976 | +13.6% | 0.12% | +8.2% |
Q1 2016 | $7,052,000 | -18.5% | 61,598 | +1.4% | 0.11% | -37.9% |
Q4 2015 | $8,655,000 | +94.8% | 60,753 | +22.8% | 0.18% | +59.5% |
Q3 2015 | $4,444,000 | -32.5% | 49,471 | -13.5% | 0.11% | -25.0% |
Q2 2015 | $6,583,000 | – | 57,159 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |